Cargando…
The Use of SARS-CoV-2-Positive Donors in Hematopoietic Stem Cell Transplantation
BACKGROUND: Since 2019, the SARS-CoV-2 pandemic has become a global issue due to its high fatality rate. Over time, the characteristics of the virus have evolved and led to the creation of an omicron strain with higher infectivity but a significantly decreased fatality rate. For patients in urgent n...
Autores principales: | Cheng, Meng, Qian, Chongsheng, Zhou, Haixia, Cao, Yaqin, Xu, Mingzhu, Zhang, Tongtong, Xue, Shengli, Sun, Aining |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10141187/ https://www.ncbi.nlm.nih.gov/pubmed/37236865 http://dx.doi.org/10.1016/j.transproceed.2023.04.027 |
Ejemplares similares
-
P518: VENETOCLAX AND AZACITIDINE COMBINED WITH CHIDAMIDE (VAC) FOR THE TREATMENT OF NEWLY DIAGNOSED ACUTE MONOCYTIC LEUKEMIA PATIENTS
por: LI, Zheng, et al.
Publicado: (2023) -
Therapeutic effects of autologous hematopoietic stem cell transplantation in multiple myeloma patients
por: FU, CHENGCHENG, et al.
Publicado: (2013) -
Allogeneic hematopoietic stem cell transplantation from non-sibling 10/10 HLA-matched related donors: a single-center experience
por: Shen, Yaoyao, et al.
Publicado: (2021) -
Hematopoietic stem cell transplantation from an infected SARS-CoV2 donor sibling
por: Anurathapan, Usanarat, et al.
Publicado: (2020) -
Hematopoietic stem cell transplantation from an infected SARS-CoV2 haploidentical donor: A case report
por: Chen, Xin, et al.
Publicado: (2023)